Breaking

What’s the Secret to Crushing the S&P 500?
Lowering the Bar: Why Lowe’s Could Head South
Biotechs Looking Up – Two Stocks To Take Advantage
Mag7 ETF Leads as Bullish Pattern Forms – Charting the Trends and Trading Setups for the Mag7 Stocks
Investors are Pouring Into Gold Miners—Here’s What You Need to Know!
Semiconductors Have More to Prove Before Breakout is Believed
The Best Five Sectors, #4
BEWARE! META, TSLA, AMZN, MSFT & AAPL Report Earnings Next Week!

Business
Investing
Stocks
Latest News
Search for:

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Stardust Power Inc. Announces Pricing of $5.75 Million Public Offering

January 25, 2025

Greenland Tanbreez Project Maiden Drill Results

January 25, 2025

Top 5 Canadian Mining Stocks This Week: Wealth Minerals Charges Up 64%

January 25, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Disclaimer: marketruleexperts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2025 marketruleexperts.com | All Rights Reserved

Top

Type above and press Enter to search. Press Esc to cancel.